Binding Site’s Immunologicals Group has completed a major expansion to their monoclonal antibody product offerings. In addition to the established conjugated and unconjugated versions of the IgG4 Clone-HP6025 and the CD23 Clone BU-3438, Binding Site has recently introduced a number of new monolclonals focused on infectious diseases, including CMV, hepatitis (A, B, C, and D), herpes, HIV,…